Aldeyra Therapeutics Inc
ALDX·Stocks·Biotechnology·United States·Nasdaq·USD
Price
$0.91
Today
-1.1%
YTD
-81.4%
About
Aldeyra Therapeutics is a biotechnology company founded in 2004 and headquartered in Lexington, Massachusetts. The company works to develop and commercialise medicines for immune-mediated ocular and systemic diseases. Listed under the ticker ALDX on the NASDAQ CM stock market, this company operates primarily within the US. Track the ALDX share price by adding it to your eToro watchlist.
Price chart
Closing price history for ALDX (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-2.39
P/S (TTM)0.00
P/B (TTM)1.46
Market cap$55.28M
Cap tierMicro-cap
Industry avg P/E-2.18
Profitability
Gross marginUnknown
EBIT margin0.00%
Net marginUnknown
ROE-49.48%
ROA-34.80%
Earnings & Revenue
Revenue (TTM)$0.00
Revenue growth (1Y)Unknown
EPS (TTM)-$0.38
Free cash flow$-22.04M
Total debt$143,447.00
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)2.69
Employees8
Next earnings4 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.